11 min listen
ACCEL Lite: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in HFrEF
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in HFrEF
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
10 minutes
Released:
Feb 14, 2023
Format:
Podcast episode
Description
Iron deficiency is very common in patients with heart failure, affecting between one third to a half of all patients. IRONMAN will help determine if treatment with intravenous iron can help patients feel better, and reduce the risk of being hospitalized for heart failure or dying. In this interview, Professor Paul Kalra MD, FRCP and Roger S. Blumenthal MD, FACC discuss IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in HFrEF. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
Released:
Feb 14, 2023
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil: The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research